Stephen Murray

1.2k total citations
16 papers, 641 citations indexed

About

Stephen Murray is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Stephen Murray has authored 16 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Stephen Murray's work include Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stephen Murray is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Stephen Murray collaborates with scholars based in United Kingdom, United States and Brazil. Stephen Murray's co-authors include Alan R. Boobis, Robert J. Edwards, Donald S. Davies, Nigel J. Gooderham, Anthony M. Lynch, David G. Watson, Shinichi Kobayashi, D. S. Davies, Mark G. Knize and D. S. Davies and has published in prestigious journals such as Biochemical Pharmacology, Carcinogenesis and Toxicology and Applied Pharmacology.

In The Last Decade

Stephen Murray

16 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Murray United Kingdom 12 307 202 178 166 103 16 641
Nancy Eddy Hopkins United States 17 434 1.4× 306 1.5× 81 0.5× 197 1.2× 92 0.9× 25 905
George J. Traiger United States 18 407 1.3× 166 0.8× 128 0.7× 127 0.8× 72 0.7× 34 816
L T Burka United States 12 179 0.6× 213 1.1× 172 1.0× 72 0.4× 89 0.9× 29 609
John W. Cameron United States 3 532 1.7× 251 1.2× 183 1.0× 220 1.3× 183 1.8× 3 863
Michael M. Iba United States 14 269 0.9× 269 1.3× 205 1.2× 103 0.6× 159 1.5× 48 697
Jun-Yan Hong United States 14 336 1.1× 325 1.6× 135 0.8× 143 0.9× 40 0.4× 15 951
Barbara S. Bock-Hennig Germany 15 332 1.1× 239 1.2× 147 0.8× 196 1.2× 100 1.0× 20 640
Helena Vadi Sweden 13 278 0.9× 286 1.4× 187 1.1× 134 0.8× 77 0.7× 19 663
Joyce Massengill United States 7 268 0.9× 358 1.8× 344 1.9× 173 1.0× 95 0.9× 9 822
Jean De Graeve Belgium 9 305 1.0× 164 0.8× 115 0.6× 125 0.8× 103 1.0× 11 578

Countries citing papers authored by Stephen Murray

Since Specialization
Citations

This map shows the geographic impact of Stephen Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Murray more than expected).

Fields of papers citing papers by Stephen Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Murray. The network helps show where Stephen Murray may publish in the future.

Co-authorship network of co-authors of Stephen Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Murray. A scholar is included among the top collaborators of Stephen Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Murray. Stephen Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Murray, Stephen, Shi Yang, Elizabeth G. Demicco, et al.. (2005). Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen‐induced rat mammary tumors. Journal of Cellular Biochemistry. 95(5). 875–884. 22 indexed citations
2.
Murray, Stephen. (2005). Handbook of Analytical Separations, Vol. 5: Drug Monitoring and Clinical Chemistry. British Journal of Clinical Pharmacology. 59(5). 605–605. 1 indexed citations
3.
Thatcher, Natalie J & Stephen Murray. (2001). Analysis of the glutathione conjugate of paracetamol in human liver microsomal fraction by liquid chromatography mass spectrometry. Biomedical Chromatography. 15(6). 374–378. 13 indexed citations
4.
Murray, Stephen. (2001). Effect of cruciferous vegetable consumption on heterocyclic aromatic amine metabolism in man. Carcinogenesis. 22(9). 1413–1420. 76 indexed citations
5.
Edwards, Robert J., et al.. (2001). Diazinon Is Activated by CYP2C19 in Human Liver. Toxicology and Applied Pharmacology. 177(1). 68–76. 82 indexed citations
6.
Murray, Stephen, et al.. (2001). Vanadate disrupts mammary gland development in whole organ culture. Developmental Dynamics. 222(3). 354–367. 4 indexed citations
7.
Murray, Stephen, et al.. (2000). Mass spectrometric detection and measurement of N2-(2′-deoxyguanosin-8-yl)PhIP adducts in DNA. Journal of Chromatography B Biomedical Sciences and Applications. 744(1). 55–64. 19 indexed citations
8.
Davies, Donald S., Nigel J. Gooderham, Stephen Murray, et al.. (1996). Chemical Methods for Assessing Systemic Exposure to Dietary Heterocyclic Amines in Man. Archives of toxicology. Supplement. 18. 251–258. 2 indexed citations
9.
Lynch, Anthony M., Stephen Murray, Nigel J. Gooderham, & Alan R. Boobis. (1995). Exposure to and activation of dietary heterocyclic amines in humans. Critical Reviews in Oncology/Hematology. 21(1-3). 19–31. 19 indexed citations
10.
Murray, Bernard P., et al.. (1993). Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis. 14(4). 585–592. 63 indexed citations
11.
Edwards, Robert J., et al.. (1993). Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochemical Pharmacology. 46(2). 213–220. 29 indexed citations
12.
Edwards, Robert J., et al.. (1993). An inhibitory monoclonal anti-protein antibody and an anti-peptide antibody share an epitope on rat cytochrome enzymes CYP1A1 and CYP1A2. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1161(1). 38–46. 9 indexed citations
13.
Lynch, Anthony M., Mark G. Knize, Alan R. Boobis, et al.. (1992). Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef.. PubMed. 52(22). 6216–23. 110 indexed citations
14.
Kobayashi, Shinichi, et al.. (1989). The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology. 38(17). 2795–2799. 117 indexed citations
15.
Boobis, Alan R., et al.. (1985). Genetic polymorphism in drug oxidation: In vitro studies of human debrisoquine 4-hydroxylase and bufuralol 1′-hydroxylase activities. Biochemical Pharmacology. 34(1). 65–71. 57 indexed citations
16.
McManus, Michael E., Alan R. Boobis, Rodney F. Minchin, et al.. (1984). Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.. PubMed. 44(12 Pt 1). 5692–7. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026